M. Hayashi

发表

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of the American College of Cardiology.

Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome.

M. Kinoshita, T. Tsutamoto, H. Horie, 2000, Japanese circulation journal.

Heart Failure Relationship Between Endothelin-1 Extraction in the Peripheral Circulation and Systemic Vascular Resistance in Patients With Severe Congestive Heart Failure

M. Kinoshita, M. Fujii, T. Tsutamoto, 2016 .

Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy.

K. Nakao, H. Tanaka, Xinwen Wang, 2001, Journal of the American College of Cardiology.

Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.

M. Kinoshita, Takashi Yamamoto, T. Yamamoto, 2001, Journal of cardiac failure.

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of the American College of Cardiology.

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

M. Kinoshita, Y. Sugimoto, M. Fujii, 1999, European heart journal.

Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 1999, Journal of the American College of Cardiology.

Effects of Long‐Acting Calcium Channel Antagonists on Neurohumoral Factors: Comparison of Nifedipine Coat‐Core with Amlodipine

M. Fujii, T. Tsutamoto, T. Tsutsui, 2003, Journal of cardiovascular pharmacology.

elationship Between Renal Function and Plasma rain Natriuretic Peptide in Patients With Heart Failure

M. Kinoshita, Takashi Yamamoto, Hiroshi Sakai, 2016 .

Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction

M. Horie, A. Taniguchi, M. Kinoshita, 2003, Circulation.

Increased von Willebrand Factor in the Endocardium as a Local Predisposing Factor for Thrombogenesis in Overloaded Human Atrial Appendage

M. Kinoshita, M. Fujii, T. Tsutamoto, 2016 .

Absolute, not relative, changes are important when interpreting trial data: Reply

M. Kinoshita, M. Fujii, T. Tsutamoto, 2001 .

[Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].

M. Hayashi, 2004, Journal of cardiology.

Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction.

M. Kinoshita, T. Yamamoto, M. Fujii, 2003, European heart journal.

Dilated Cardiomyopathy Relationship Between Tumor Necrosis Factor-Alpha Production and Oxidative Stress in the Failing Hearts of Patients With Dilated Cardiomyopathy

M. Kinoshita, Y. Sugimoto, Takashi Yamamoto, 2016 .

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.

M. Kinoshita, T. Tsutamoto, T. Tsutsui, 2002, Journal of the American College of Cardiology.

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.

M. Kinoshita, Y. Sugimoto, Takashi Yamamoto, 2001, Journal of the American College of Cardiology.

Transcardiac Gradient of Aldosterone Before and After Spironolactone in Patients with Congestive Heart Failure

Takashi Yamamoto, M. Fujii, T. Tsutamoto, 2003, Journal of cardiovascular pharmacology.

Transcardiac extraction of circulating endothelin-1 across the failing heart.

M. Kinoshita, Y. Sugimoto, M. Fujii, 2000, The American journal of cardiology.

The role of aldosterone blocker on left ventricular remodeling

M. Horie, Makoto Ito, Takashi Yamamoto, 2008 .

Relationship between interleukin-6 production in the lungs and pulmonary vascular resistance in patients with congestive heart failure.

M. Kinoshita, T. Tsutamoto, K. Maeda, 2002, Chest.

Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction.

M. Kinoshita, T. Tsutamoto, K. Maeda, 2000, Journal of applied physiology.

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction.

M. Kinoshita, T. Tsutamoto, T. Tsutsui, 2001, Journal of the American College of Cardiology.

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2001, Journal of the American College of Cardiology.

Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.

M. Kinoshita, Y. Sugimoto, M. Fujii, 2000, Journal of the American College of Cardiology.

Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.

M. Kinoshita, T. Yamamoto, M. Fujii, 2001, Journal of the American College of Cardiology.

Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.

M. Horie, M. Kinoshita, Takashi Yamamoto, 2006, Journal of the American College of Cardiology.

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial.

Y. Ouchi, S. Yamashita, Y. Ohashi, 2019, Circulation.